Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
FAQs about Glaxosmithkline Pharmaceuticals share price
Glaxosmithkline Pharmaceuticals is trading at 2723.20 as on Fri Nov 01 2024 13:29:54. This is 0.13% upper as compared to its previous closing price of 2719.80.
The market capitalization of Glaxosmithkline Pharmaceuticals is 46132.65 Cr as on Fri Nov 01 2024 13:29:54.
The average broker rating on Glaxosmithkline Pharmaceuticals is Buy. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 2 analysts have given a hold rating
- 0 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Glaxosmithkline Pharmaceuticals is 3087.95 whereas the 52 wk low is 1387.90
Glaxosmithkline Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 69.45
- Sector P/E: 33.75
- Dividend Yield: 1.18%
- D/E ratio: 0.01
Glaxosmithkline Pharmaceuticals reported a net profit of 589.96 Cr in 2024.
Glaxosmithkline Pharmaceuticals Quick Links
Glaxosmithkline Pharmaceuticals Dividend Glaxosmithkline Pharmaceuticals Bonus Glaxosmithkline Pharmaceuticals News Glaxosmithkline Pharmaceuticals AGM Glaxosmithkline Pharmaceuticals Rights Glaxosmithkline Pharmaceuticals Splits Glaxosmithkline Pharmaceuticals Board Meetings Glaxosmithkline Pharmaceuticals Key Metrics Glaxosmithkline Pharmaceuticals Shareholdings Glaxosmithkline Pharmaceuticals Profit Loss Glaxosmithkline Pharmaceuticals Balance Sheet Glaxosmithkline Pharmaceuticals Cashflow Glaxosmithkline Pharmaceuticals Q1 Results Glaxosmithkline Pharmaceuticals Q2 Results Glaxosmithkline Pharmaceuticals Q3 Results Glaxosmithkline Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks